Home > Insider Trading > Filing (0001225208-13-025632)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
9892	Bard C R Inc	BCR	Surgical & Medical Instruments & Apparatus (3841)	221454160

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1463423	C Jim Beasley	C/O C. R. Bard, Inc. 730 Central Avenue Murray Hill NJ 07974	Group President	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2013-12-16	14,970	$86.15	54,463	No	4	M	Direct
Common Stock	Acquisiton	2013-12-16	8,656	$84.58	63,119	No	4	M	Direct
Common Stock	Disposition	2013-12-16	1,557	$134.33	61,562	No	4	S	Direct
Common Stock	Disposition	2013-12-16	22,069	$133.48	39,493	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Option (Right to Buy)	Disposition	2013-12-16	14,970	$0.00	14,970	$86.15
Common Stock	Option (Right to Buy)	Disposition	2013-12-16	8,656	$0.00	8,656	$84.58

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2020-12-08	No	4	M	Direct
17,312		2021-12-14	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	3,076	Indirect	401(k) Plan

Footnotes

Option exercise and sales are pursuant to a previously disclosed 10b5-1 plan.
Represents the weighted average sales price for price increments ranging from $134.21 to $134.54. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
Represents the weighted average sales price for price increments ranging from $133.09 to $134.04. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
Performance options granted under 2003 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated).
Options fully vested upon achievement of certain performance criteria.
Options granted under the 2003 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated).
Of this option grant, 8,656 options vested on December 14, 2013, and the remaining options vest in two annual installments beginning on December 14, 2014.